79 related articles for article (PubMed ID: 12970775)
1. Small-molecule inhibitors of signal transduction pathways in leukemia therapeutics: how to assess selectivity for malignant signals.
White MK
Leukemia; 2003 Sep; 17(9):1759-61. PubMed ID: 12970775
[No Abstract] [Full Text] [Related]
2. Protein kinase inhibitors as a therapeutic modality.
Levitzki A
Acc Chem Res; 2003 Jun; 36(6):462-9. PubMed ID: 12809533
[TBL] [Abstract][Full Text] [Related]
3. Targeting peroxiredoxins against leukemia.
Liu CX; Zhou HC; Yin QQ; Wu YL; Chen GQ
Exp Cell Res; 2013 Jan; 319(2):170-6. PubMed ID: 22728267
[TBL] [Abstract][Full Text] [Related]
4. Molecular therapeutic approaches to acute myeloid leukemia: targeting aberrant chromatin dynamics and signal transduction.
Piazza F; Semenzato G
Expert Rev Anticancer Ther; 2004 Jun; 4(3):387-400. PubMed ID: 15161438
[TBL] [Abstract][Full Text] [Related]
5. Issues and progress with protein kinase inhibitors for cancer treatment.
Dancey J; Sausville EA
Nat Rev Drug Discov; 2003 Apr; 2(4):296-313. PubMed ID: 12669029
[TBL] [Abstract][Full Text] [Related]
6. Challenges of developing therapeutics that target signal transduction in patients with gynecologic and other malignancies.
Rowinsky EK
J Clin Oncol; 2003 May; 21(10 Suppl):175s-186s. PubMed ID: 12743132
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction inhibitors in chronic lymphocytic leukemia.
Ma S; Rosen ST
Curr Opin Oncol; 2011 Nov; 23(6):601-8. PubMed ID: 21892084
[TBL] [Abstract][Full Text] [Related]
8. [Targeting Ras related proteins for leukemia therapy].
Kimura S; Maekawa T
Rinsho Ketsueki; 2005 Mar; 46(3):179-86. PubMed ID: 16447712
[No Abstract] [Full Text] [Related]
9. The Raf/MEK/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia.
Lee JT; McCubrey JA
Leukemia; 2002 Apr; 16(4):486-507. PubMed ID: 11960326
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitors for Notch and gamma-secretase. Biology of T-cell leukemia].
Yahagi Y; Usui N
Gan To Kagaku Ryoho; 2009 May; 36(5):744-8. PubMed ID: 19496283
[No Abstract] [Full Text] [Related]
11. Small-molecule and antibody approaches to molecular chemotherapy of primary brain tumors.
Newton HB
Curr Opin Investig Drugs; 2007 Dec; 8(12):1009-21. PubMed ID: 18058572
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Raf/MEK/ERK pathway with small-molecule inhibitors.
McCubrey JA; Milella M; Tafuri A; Martelli AM; Lunghi P; Bonati A; Cervello M; Lee JT; Steelman LS
Curr Opin Investig Drugs; 2008 Jun; 9(6):614-30. PubMed ID: 18516761
[TBL] [Abstract][Full Text] [Related]
13. Farnesyltransferase inhibitors (FTIs) in myeloid malignancies.
Karp JE; Lancet JE
Ann Hematol; 2004; 83 Suppl 1():S87-8. PubMed ID: 15124688
[TBL] [Abstract][Full Text] [Related]
14. [The tyrosine kinase antagonist imatinib mesylate].
Heinzl S
Med Monatsschr Pharm; 2002 Jan; 25(1):4-7. PubMed ID: 11826665
[No Abstract] [Full Text] [Related]
15. [Tyrosine kinase inhibitor STI571--a breakthrough in leukemia treatment?].
Czechowska A; Błasiak J
Postepy Biochem; 2003; 49(3):157-67. PubMed ID: 15083608
[No Abstract] [Full Text] [Related]
16. Target of rapamycin signaling in leukemia and lymphoma.
Vu C; Fruman DA
Clin Cancer Res; 2010 Nov; 16(22):5374-80. PubMed ID: 20826559
[TBL] [Abstract][Full Text] [Related]
17. Role of tyrosine kinase inhibitors in cancer therapy.
Arora A; Scholar EM
J Pharmacol Exp Ther; 2005 Dec; 315(3):971-9. PubMed ID: 16002463
[TBL] [Abstract][Full Text] [Related]
18. Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells.
Muranyi AL; Dedhar S; Hogge DE
Exp Hematol; 2009 Apr; 37(4):450-60. PubMed ID: 19302919
[TBL] [Abstract][Full Text] [Related]
19. Novel therapies for patients with chronic myeloid leukemia.
Giles FJ; Kantarjian H; Cortes J
Expert Rev Anticancer Ther; 2004 Apr; 4(2):271-82. PubMed ID: 15056057
[TBL] [Abstract][Full Text] [Related]
20. Protein-protein interactions as targets for small-molecule therapeutics in cancer.
White AW; Westwell AD; Brahemi G
Expert Rev Mol Med; 2008 Mar; 10():e8. PubMed ID: 18353193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
